⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3194321 | 0.77 | DAO (0.35) | — | |
| SCHEMBL1566543 | 0.74 | — | — | |
| SCHEMBL5136344 | 0.72 | — | — | |
| SCHEMBL85297 | 0.72 | — | — | |
| SCHEMBL9918670 | 0.72 | — | — | |
| SCHEMBL9402161 | 0.72 | — | — | |
| SCHEMBL10506831 | 0.72 | HDAC1 (0.41) | — | |
| SCHEMBL11741569 | 0.72 | — | — | |
| SCHEMBL1042017 | 0.72 | — | — | |
| SCHEMBL29994134 | 0.72 | RAB9A (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115300640-A | Novel linkers and their use for specific coupling of drugs and biomolecules | 杭州多禧生物科技有限公司 | 2022-11-08 | — | — | CN | claimed |
| US-20180140722-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF HEART FAILURE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-05-24 | — | — | US | claimed |
| US-20170105952-A1 | HISTONE ACETYL TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2017-04-20 | — | — | US | claimed |
| WO-2016164482-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF HEART FAILURE | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2016-10-13 | — | — | WO | claimed |
| US-20150246010-A1 | HISTONE ACETYL TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2015-09-03 | — | — | US | claimed |
| US-20100144885-A1 | HISTONE ACETYL TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2010-06-10 | — | — | US | claimed |
| EP-2073812-A2 | HISTONE ACETYLE TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM | The Board of Trustees of the University of Illinois (US) | 2009-07-01 | — | — | EP | claimed |
| EP-2040731-A2 | SOLID ORAL DOSAGE FORM CONTAINING AN ENHANCER | Merrion Research III Limited (IE) | 2009-04-01 | — | — | EP | claimed |
| WO-2008042795-A2 | HISTONE ACETYLE TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2008-04-10 | — | — | WO | claimed |
| WO-2007146234-A2 | SOLID ORAL DOSAGE FORM CONTAINING AN ENHANCER | MERRION RESEARCH II LIMITED (IE) | 2007-12-21 | — | — | WO | claimed |
| US-20070292512-A1 | Solid Oral Dosage Form Containing an Enhancer | MERRION RESEARCH II LIMITED (IE) | 2007-12-20 | — | — | US | claimed |
| US-20070148228-A1 | Solid oral dosage form containing an enhancer | MERRION RESEARCH I LIMITED (IE) | 2007-06-28 | — | — | US | claimed |
| CN-117866042-A | Disulfide-containing cell penetrating peptides and methods of making and using the same | 俄亥俄州国家创新基金会 | 2024-04-12 | — | — | CN | disclosed |
| US-11938105-B1 | Methods and compositions for the treatment of cancer cachexia | OHIO STATE INNOVATION FOUNDATION (US) | 2024-03-26 | — | — | US | disclosed |
| CN-110114075-B | Disulfide-containing cell penetrating peptides and methods of making and using the same | 俄亥俄州国家创新基金会 | 2024-01-12 | — | — | CN | disclosed |
| CN-116785293-A | Compounds and methods for treating infections | 尼奥酷里私人有限公司 | 2023-09-22 | — | — | CN | disclosed |
| US-20070148228-A1 | Solid oral dosage form containing an enhancer | MERRION RESEARCH I LIMITED (IE) | 2007-06-28 | — | — | US | disclosed |
| EP-1745032-A2 | CXCR1 AND CXCR2 CHEMOKINE ANTAGONISTS | Schering Cooperation (US) | 2007-01-24 | — | — | EP | disclosed |
| US-20060014794-A1 | CXCR1 and CXCR2 chemokine antagonists | SCHERING CORPORATION | 2006-01-19 | — | — | US | disclosed |
| WO-2005113534-A2 | CXCR1 AND CXCR2 CHEMOKINE ANTAGONISTS | SCHERING CORPORATION (US) | 2005-12-01 | — | — | WO | disclosed |